Stock Analiz

CHE vs LFST stock comparison

Chemed vs. LifeStance Health Group · data as of November 13, 2026

Chemed (CHE) has a market value of about $7.1B, LifeStance Health Group (LFST) about $5.4B. Over their latest twelve months Chemed had revenue of $2.7B and LifeStance Health Group $1.7B.

On our five checks Chemed scores higher: 2.4 out of 5 (weak) against 1.8 (weak).

By area, the stronger company is LifeStance Health Group on future growth; Chemed on track record; Chemed on financial health; Chemed on shareholder returns.

Chemed is cheaper on earnings (P/E 26.3 vs. 74.1), while LifeStance Health Group grew revenue faster over five years (46.3% vs. 4.0% a year).

Chemed leads on 16 of the compared lines and LifeStance Health Group on 5.

Side by side

CHELFST
Size and price
Market cap$7.1B$5.4B
Share price$548.20$14.08
Score
Overall score (of 5)2.41.8
Value00
Future growth03
Track record31
Financial health54
Shareholder returns41
Valuation
P/E (TTM)26.374.1
Forward P/E20.033.3
Price / free cash flow24.129.9
Price / sales2.73.2
EV / EBITDA17.137.9
PEG—6.58
DCF value vs. price−7%−63%
Business
Revenue$2.7B$1.7B
Net income$282M$72M
Free cash flow$295M$179M
Net margin10.6%4.3%
Gross margin (5-yr avg.)35.0%—
ROIC (5-yr avg.)23.7%-6.9%
Growth
Revenue growth (1 yr)4.1%13.9%
Revenue growth (5 yrs, per year)4.0%46.3%
EPS growth (5 yrs, per year)-1.2%—
Balance sheet and payouts
Net cash (cash minus debt)-$344M-$259M
Dividend yield0.51%None
Shareholder yield6.6%0.0%
Analysts
Upside to average target+13%+19%
Consensus ratingBuyBuy

Highlighted = the better figure on that line. Revenue, net income and free cash flow: CHE TTM to September 30, 2026, LFST TTM to September 30, 2026. Not investment advice.

Frequently asked questions

Which is the better stock, Chemed or LifeStance Health Group?

We do not give buy or sell advice. On our five checks (value, growth, track record, financial health and shareholder returns) Chemed scores 2.4 out of 5 and LifeStance Health Group 1.8; the table shows where each one is stronger.

Is Chemed cheaper than LifeStance Health Group?

On trailing earnings, Chemed trades at a P/E of 26.3 and LifeStance Health Group at 74.1, so Chemed is cheaper by this measure. A lower P/E can also reflect slower expected growth.

Which grows faster, Chemed or LifeStance Health Group?

Over five years LifeStance Health Group grew revenue about 46.3% a year and Chemed about 4.0% a year.

Which pays a higher dividend?

Chemed yields 0.51% and LifeStance Health Group nothing (no dividend).

Full Chemed analysis → Full LifeStance Health Group analysis →

More comparisons

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.